InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Huang Michael F.. Director active across 1 company, notably Soleno Therapeutics INC. Aggregated, 3 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €23k. History available since 17 July 2024. The latest transaction was disclosed on 27 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations